Mounjaro (Tirzepatide) is a weight loss drug that acts on both GLP-1 and GIP receptors
when using the sweet stuff, choose natural options like fruit, maple syrup, or honey in moderation
Patients shed as much as 120 pounds, their cholesterol dropped, their prediabetes faded, and they cut down on blood-pressure meds
As well, in real-world scenarios, such as described by Brindisi et al, it is mentioned a reduction in pleasure and taste perception in overweight and people with obesity with poor type 2 diabetes control, probably by lowering the detection threshold of sweet flavors, becoming more sensitive to them, resulting in aversion for this flavor (175)
Additional safety considerations include: risk of hypoglycemia when used with insulin or sulfonylureas (dose adjustments may be needed)